Jan Pelipenko

Title: Jan Pelipenko: Innovator in Pharmaceutical Formulations

Introduction

Jan Pelipenko is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative formulations. His work focuses on enhancing the solubility and effectiveness of medications, which is crucial for patient treatment.

Latest Patents

Jan Pelipenko holds a patent for an afatinib-containing formulation. This invention refers to a process for preparing granules or particles comprising afatinib dimaleate. The process involves providing afatinib dimaleate and at least one pharmaceutically acceptable excipient. It also includes preparing granules or particles using at least one solvent selected from organic solvents and water. The invention ensures that all excipients used have neutral or acidic properties, and that afatinib dimaleate has a solubility of at least 5 mg/ml in the solvent. This patent is essential for developing effective pharmaceutical compositions for treating specific diseases.

Career Highlights

Throughout his career, Jan Pelipenko has demonstrated a commitment to advancing pharmaceutical science. His innovative approach to drug formulation has led to the successful development of new therapeutic options. With a focus on improving drug solubility, he has contributed to the enhancement of treatment efficacy for various medical conditions.

Collaborations

Jan has collaborated with talented professionals in his field, including Katja Kristan and Marko Oblak. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jan Pelipenko is a distinguished inventor whose work in pharmaceutical formulations has the potential to significantly impact patient care. His patent for an afatinib-containing formulation exemplifies his dedication to improving medication effectiveness. Through his innovative contributions, he continues to advance the field of pharmaceuticals.